Previous 10 | Next 10 |
Nevro (NVRO +6.8%) stock edged higher after the medical device maker disclosed that CEO and chairman Keith Grossman bought 3.2K shares at $63.59 worth ~$200K. Grossman now holds ~169.3K shares in NVRO. For further details see: Nevro stock rises after CEO buys shares worth $200K
Nevro Announces Positive Medicare Coverage Update from Noridian for the Treatment of Painful Diabetic Neuropathy PR Newswire REDWOOD CITY, Calif. , March 7, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is deliverin...
The following slide deck was published by Nevro Corp. in conjunction with their 2021 Q4 earnings call. For further details see: Nevro Corp. 2021 Q4 - Results - Earnings Call Presentation
Nevro Corp. (NVRO) Q4 2021 Earnings Conference Call February 23, 2022 4:30 P.M. ET Company Participants Julie Dewey - Corporate Communications and Investor Relations Officer Keith Grossman - Chairman, Chief Executive Officer and President Rod MacLeod - Chief Financial Officer Conference Call ...
Nevro press release (NYSE:NVRO): Q4 GAAP EPS of -$0.86 in-line. Revenue of $102.76M (-6.3% Y/Y) beats by $2.06M. Q1 2022 Guidance: Revenue expected to be in the range of $85 Million to $87 Million vs, consensus of $92.42 million; and Non-GAAP Adjusted EBITDA Guidance of Negative $19 Million t...
Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance PR Newswire REDWOOD CITY, Calif. , Feb. 23, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), delivering comprehensive, life-changing soluti...
Nevro to Participate in Wells Fargo 2022 MedTech R&D Spotlight Call Series Nevro to Participate in Wells Fargo 2022 MedTech R&D Spotlight Call Series Friday, March 4, 2022 at 10:00 am Eastern Time PR Newswire REDWOOD CITY, Calif. , Feb. 18, 2022 /...
Nevro Announces Publication of 12-Month Data from SENZA-NSRBP Randomized Controlled Trial in Journal of Neurosurgery: Spine Results Show Profound Improvement in Non-Surgical Refractory Back Pain Patients Receiving 10 kHz Spinal Cord Stimulation Therapy Relative to Conventional M...
Nevro to Present at Citi's 2022 Virtual Healthcare Conference Thursday, February 24, 2022 at 12:30 pm Eastern Time PR Newswire REDWOOD CITY, Calif. , Jan. 31, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is deliveri...
Nevro Named to 2022 Bloomberg Gender-Equality Index Leading Indicator Aimed at Increasing Transparency Surrounding Gender-Related Practices and Policies PR Newswire REDWOOD CITY, Calif. , Jan. 26, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a glo...
News, Short Squeeze, Breakout and More Instantly...
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 PR Newswire REDWOOD CITY, Calif. , July 9, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-chan...
Nevro to Present at Truist Securities MedTech Conference PR Newswire REDWOOD CITY, Calif. , June 11 , 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chr...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif. , May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the trea...